Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
10/10/1991 | DE4011375A1 New anticoagulant hirudin-polyvinyl lactam conjugates - for treating e.g. myocardial infarction, peripheral arterial occlusion disorders, deep venous thrombosis and pulmonary embolism |
10/10/1991 | DE4011207A1 Humane splenopentinderivate und verfahren zu deren herstellung Human splenopentinderivate and processes for their preparation |
10/10/1991 | CA2080371A1 T-cell suppressor protein |
10/09/1991 | EP0450936A1 Monoclonal antibody to avermectins |
10/09/1991 | EP0450800A1 Utilization and delivery of enzymes |
10/09/1991 | EP0450598A2 Inhibitors of the advanced glycosylation of proteins and methods of use therefor |
10/09/1991 | EP0450573A2 Antibodies for the treatment and diagnosis of Pseudomonas aeruginosa infections |
10/09/1991 | EP0450480A2 Somatostatin Analogues |
10/09/1991 | EP0450479A1 Bispecific monoclonal anti-bodies, their production and use |
10/09/1991 | EP0450472A1 Monoclonal antibodies that inhibit growth of kaposi's sarcoma |
10/09/1991 | EP0450461A2 LHRH Analogs |
10/09/1991 | EP0450412A1 Heat-treated IgM antibody preparations |
10/09/1991 | EP0450386A2 Production of biologically active, recombinant members of the NGF/BDNF family of neurotrophic proteins |
10/09/1991 | EP0450352A1 Liposome formulations of immunomodulating drugs for the topical and aerosol administrations |
10/09/1991 | EP0450240A1 Anti-aids preparation |
10/09/1991 | EP0450100A1 Physiologically active peptide |
10/09/1991 | EP0450095A1 Method of assaying d-vanillylmandelic acid, and reagent and kit therefor |
10/09/1991 | EP0449973A1 Polypeptide-polymer conjugates active in wound healing. |
10/09/1991 | EP0449972A1 Triple stranded nucleic acid and methods of use |
10/09/1991 | EP0449968A1 PROCESS FOR THE PREPARATION OF HUMAN DNase |
10/09/1991 | EP0449956A1 Novel lymphokine/cytokine genes |
10/09/1991 | EP0449949A1 Use of interleukin-4 for lowering blood-cholesterol levels |
10/09/1991 | EP0449948A1 Grafting genetically modified cells to treat diseases of the central nervous system |
10/09/1991 | EP0449943A1 Transdermal and intranasal administration of renin inhibitory peptides |
10/09/1991 | EP0449915A1 New tnf peptides |
10/09/1991 | EP0449884A1 Derivatives of tetrapeptides as cck agonists |
10/09/1991 | EP0449879A1 Heterobifunctional antibodies having specificity for platelets and thrombolytic agents |
10/09/1991 | EP0449856A1 Pneumolysin mutants and pneumococcal vaccines made therefrom |
10/09/1991 | EP0449828A1 HUMAN Fc$g(g) RECEPTOR III |
10/09/1991 | EP0231236B1 Purification of hemoglobin and modified hemoglobin by affinity chromatography |
10/09/1991 | CN1055116A Method for producting pharmaceutical composition containing il-4 as active ingredient |
10/08/1991 | WO1991015220A1 Products containing a lithium salt and a tumour necrosis factor |
10/08/1991 | US5055591 Process for the preparation of octahydropenta(b)pyrrole carboxylates |
10/08/1991 | US5055554 Renal growth promoter and process for the production of the same |
10/08/1991 | US5055553 Low molecular weight pulmonary surfactant proteins |
10/08/1991 | US5055483 Hypotensive agents, cognition activators, learning enrichment |
10/08/1991 | US5055464 Cognition activators, diuretics, antiulcer agents |
10/08/1991 | US5055455 Inhibiting adhesion of coagulase-negative staphylococcus to a polymeric material |
10/08/1991 | US5055451 Prevent tissue damage |
10/08/1991 | US5055450 Di-, tri- and tetrapeptides as inhibitors of human leukocyte elastase |
10/08/1991 | US5055449 With peptide to reduce neuropathic side effects |
10/08/1991 | US5055448 Diuretics |
10/08/1991 | US5055447 Administering transforming growth factor beta |
10/08/1991 | US5055446 Less than ten percent of calories from protein, remainder is from lipids and carbohydrates |
10/08/1991 | US5055400 Cloning and expression of leukotoxin gene of pasteurella in suitable host microorganism |
10/08/1991 | US5055391 Method and kit or detecting antibodies to antigens of human immunodeficiency virus type 2 (hiv-2) |
10/08/1991 | US5055302 Nearsightedness |
10/08/1991 | US5055295 Synergistic |
10/08/1991 | US5055291 Compositions for preventing secondary cataracts |
10/08/1991 | US5055289 Dual specificity against therapeutically active agent and against a disease related antigen |
10/08/1991 | US5055287 For oral cavitiy; containing peroxidase, peroxide and iodide salt with decolorizer such as malonic acid, sorbic acid |
10/08/1991 | CA2065012A1 Products containing a lithium salt and a tumor necrosis fac tor |
10/08/1991 | CA1290267C Human anti-inflammatory phospholipase inhibitor protein |
10/08/1991 | CA1290249C COMBINATION THERAPY USING INTERLEUKIN-2 AND/OR INTERFERON-.beta. AND TUMOR NECROSIS FACTOR |
10/08/1991 | CA1290248C Treatment of infections with lymphokines |
10/08/1991 | CA1290245C Methods for diagnosis and therapy of multiple sclerosis |
10/07/1991 | WO1991015516A2 Hepatitis c virus epitopes |
10/07/1991 | WO1991015515A1 Method and composition for treating thrombosis |
10/07/1991 | WO1991015230A1 Ligand for the neu gene product |
10/07/1991 | CA2079606A1 Method and composition for treating thrombosis |
10/07/1991 | CA2039985A1 Method of curing and preventing obesity by o-amylase inhibitor |
10/07/1991 | CA2039908A1 Lhrh analogues |
10/07/1991 | CA2039880A1 Somatostatin analogues |
10/07/1991 | CA2038978A1 Antibodies for the treatment and diagnosis of pseudomonas aeruginosa infections |
10/06/1991 | CA2039628A1 Platelet-aggregation inhibitors |
10/06/1991 | CA2039541A1 Monoclonal antibodies to avermectins |
10/05/1991 | WO1991015575A1 Hepatitis c virus protease |
10/05/1991 | WO1991015229A1 Modified heparin binding growth factors |
10/05/1991 | WO1991015222A2 Method of predisposing mammals to accelerated tissue repair |
10/05/1991 | CA2079604A1 Modified heparin binding growth factors |
10/05/1991 | CA2078547A1 Method of predisposing mammals to accelerated tissue repair |
10/05/1991 | CA2013900A1 Anti-aids preparation |
10/04/1991 | WO1991015512A2 Hiv envelope polypeptides |
10/04/1991 | WO1991015510A1 Epithelins: novel cysteine - rich growth modulating proteins |
10/04/1991 | WO1991015239A1 Purified antibodies specifically directed against the lipopolysaccharides (lps) of gram negative bacteria |
10/04/1991 | CA2079804A1 Purified antibodies specifically directed against the lipopolysaccharides (lps) of gram negative bacteria |
10/04/1991 | CA2079218A1 Epithelins: novel cysteine-rich growth modulating proteins |
10/04/1991 | CA2078545A1 Hiv envelope polypeptides |
10/04/1991 | CA2039542A1 Inhibitors of the advanced glycosylation of proteins and methods of use therefor |
10/04/1991 | CA2022523A1 Chemically modified cd4 peptide fragments having anti-retroviral properties |
10/03/1991 | WO1991015593A1 Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals |
10/03/1991 | WO1991014790A1 Inhibitors of transcription activation activity of papillomaviruses |
10/03/1991 | WO1991014785A1 High level expression of basic fibroblast growth factor having a homogeneous n-terminus |
10/03/1991 | WO1991014777A1 Isoform of platelet-derived growth factor a chain |
10/03/1991 | WO1991014775A1 Gp75 as a tumor vaccine for melanoma |
10/03/1991 | WO1991014772A1 Production of enzymes in seeds and their use |
10/03/1991 | WO1991014767A1 Method for enhanced growth and proliferation of mast cells |
10/03/1991 | WO1991014704A2 Treatment of polycystic ovarian disease |
10/03/1991 | WO1991014702A1 Anti-tumour peptides |
10/03/1991 | WO1991014701A1 Improved major histocompatibility complex (mhc) molecules |
10/03/1991 | WO1991014698A1 Marine tyrosinase gene |
10/03/1991 | WO1991014695A1 Insect retinoid receptor compositions and methods |
10/03/1991 | WO1991014454A1 Pharmaceutical formulations |
10/03/1991 | WO1991014451A1 Bcrf1 antagonists for treating epstein-barr virus infections |
10/03/1991 | WO1991014450A1 Use of il-4 to enhance immune response to infectious antigenic challenges |
10/03/1991 | WO1991014449A1 Induction of protection against viral infection |
10/03/1991 | WO1991014448A1 New proteins, peptides and corresponding dna or rna sequences and probes useful for diagnosing tuberculosis |
10/03/1991 | WO1991014446A1 Crf analogs |
10/03/1991 | WO1991014444A1 Treatment of cachexia with interleukin 2 |
10/03/1991 | WO1991014443A1 A method for regulating neuron development and maintenance |